{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:19:49Z","timestamp":1787822389896,"version":"build-2784847793"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Mechlorethamine is commonly prescribed to dogs at 3\u2009mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    . The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma. The secondary objectives were to describe the toxicity associated with increased mechlorethamine dose and to evaluate the response in treatment\u2010naive dogs treated at the MTD. Dogs with histologically or cytologically confirmed intermediate to large cell lymphoma were enrolled using a 3\u2009+\u20093 dose escalation model, starting at 3.5\u2009mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    mechlorethamine IV, with planned dose increments of 10%\u201315% between cohorts. Adverse events were monitored per VCOG\u2010CTCAE guidelines. Dose\u2010limiting toxicity was defined as any grade 3 or 4 adverse event. Thirty dogs were enrolled across nine cohorts. Two dogs treated at 12.3\u2009mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    developed asymptomatic grade 4 neutropenia 7\u2009days after mechlorethamine administration, leading to a MTD of 10.7\u2009mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    . Low\u2010grade vomiting, diarrhoea, and inappetence were recorded amongst dogs at several dose levels and were managed with supportive medications. Six of 10 chemotherapy\u2010na\u00efve dogs treated at the MTD, representing a separate cohort, showed partial responses (PR) 7\u2009days post\u2010administration; however, PR was also observed at dosages ranging from 3.5 to 12.3\u2009mg\/m\n                    <jats:sup>2<\/jats:sup>\n                    in pre\u2010treated patients. A higher dose of mechlorethamine than previously reported can be safely administered as a single agent to dogs. Increasing the dose of mechlorethamine in combination therapies might offer greater therapeutic benefits.\n                  <\/jats:p>","DOI":"10.1111\/vco.70025","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T03:31:41Z","timestamp":1762486301000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase 1 Dose Escalation of Single\u2010Agent Mechlorethamine in Dogs With Lymphoma"],"prefix":"10.1111","volume":"24","author":[{"given":"Laura E.","family":"Chadsey","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences North Carolina State University College of Veterinary Medicine  Raleigh North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences North Carolina State University College of Veterinary Medicine  Raleigh North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-8592","authenticated-orcid":false,"given":"Joanne L.","family":"Intile","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences North Carolina State University College of Veterinary Medicine  Raleigh North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2002.tb02390.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2008.00170.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0289.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12913"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.718967"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13979"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0195.x"},{"key":"e_1_2_9_9_1","first-page":"21","volume-title":"TNM Classification of Tumors in Domestic Animals","author":"Owen L. N.","year":"1980"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12677"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2009.00200.x"},{"key":"e_1_2_9_12_1","first-page":"189","volume-title":"Cancer: Principles and Practice of Oncology, 10th Ed","author":"Tew K. D.","year":"2014"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1958.192.2.410"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196601000-00008"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01006964"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.20.3.390"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16723"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.18.1469"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.03.009"},{"key":"e_1_2_9_20_1","first-page":"233","article-title":"Dose and Outcome: The Hurdle of Neutropenia (Review)","volume":"16","author":"Marangolo M.","year":"2006","journal-title":"Oncology Reports"},{"key":"e_1_2_9_21_1","first-page":"121","volume-title":"Important Advances in Oncology","author":"Hryniuk W. M.","year":"1988"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7286"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16875"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci2030150"},{"key":"e_1_2_9_25_1","unstructured":"Merck & Co Inc \u201cMustargen (Mechlorethamine HCL for injection). Package Insert \u201d(1999)."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.09.016"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.0898"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb02940.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.0005.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.5326\/JAAHA-MS-6878"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.13022"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1961.73040460013007e"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.13805"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.70025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vco.70025","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.70025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:37:29Z","timestamp":1787819849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vco.70025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/vco.70025"],"URL":"https:\/\/doi.org\/10.1111\/vco.70025","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"2025-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}